SCHEMBL3914867

SCHEMBL3914867

CC(C)Pc1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.36
TAAR1 Q96RJ0 6/20 0.33
LMNA P02545 3/20 0.33
SLC6A2 P23975 2/20 0.33
TSHR P16473 2/20 0.33
ALOX12 P18054 2/20 0.33
MAOA P21397 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
GLA P06280 1/20 0.33
CA3 P07451 1/20 0.33
CA4 P22748 1/20 0.33
CA9 Q16790 1/20 0.33
CA14 Q9ULX7 1/20 0.33
ACHE P22303 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
CYP2A6 P11509 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2153907 0.97 TDP1 (0.35) TDP1TAAR1LMNASLC6A2TSHR
SCHEMBL14603796 0.97 TDP1 (0.35) TDP1TAAR1LMNASLC6A2TSHR
Bromide SCHEMBL25226061 0.97 TDP1 (0.35) TDP1TAAR1LMNASLC6A2TSHR
SCHEMBL1422220 0.88 TDP1 (0.30) TDP1
Hydrochloric Acid SCHEMBL4632279 0.86 TDP1 (0.33) TDP1
Hydrochloric Acid SCHEMBL1421974 0.86
SCHEMBL4242152 0.82 TDP1 (0.36) TDP1TAAR1LMNASLC6A2TSHR
SCHEMBL2220314 0.82 TAAR1 (0.39) TDP1TAAR1LMNASLC6A2TSHR
SCHEMBL755582 0.76 TAAR1 (0.39) TAAR1LMNATSHRADRA2AADRA2C
SCHEMBL3712992 0.76 TAAR1 (0.34) TAAR1LMNASLC6A2ALOX12MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103201036-B Catalyst composition for hydroformylation reaction and a hydroformylation process using the same LG CHEMICAL LTD 2015-04-15 CN claimed
CN-103201036-A Catalyst composition for hydroformylation reaction and a hydroformylation process using the same LG CHEMICAL LTD 2013-07-10 CN claimed
EP-4667507-A1 METHOD FOR PRODUCING THERMOPLASTIC RESIN, THERMOPLASTIC RESIN OBTAINED BY SAID PRODUCTION METHOD, AND OPTICAL LENS INCLUDING SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2025-12-24 EP disclosed
US-12441880-B2 Poly(ester)carbonate and method for producing poly(ester)carbonate TEIJIN LIMITED (JP) 2025-10-14 US disclosed
EP-3733734-B1 POLY(ESTER)CARBONATE AND METHOD FOR PRODUCING POLY(ESTER)CARBONATE TEIJIN LTD (JP) 2024-03-06 EP disclosed
US-20230051676-A1 POLYCARBONATE AND METHOD FOR PRODUCING POLYCARBONATE TEIJIN LIMITED (JP) 2023-02-16 US disclosed
US-11505698-B2 Polyester carbonate and method for producing polyester carbonate TEIJIN LIMITED (JP) 2022-11-22 US disclosed
CN-113321683-B Compounds containing P-N bonds and preparation method thereof 南开大学 2022-08-26 CN disclosed
CN-111527125-B Poly (ester) carbonate and method for producing poly (ester) carbonate 帝人株式会社 2022-07-22 CN disclosed
CN-113087742-B Phosphine chiral center containing compound, organic transition metal complex and preparation method thereof 中国科学技术大学 2022-05-13 CN disclosed
US-20210371650-A1 POLY(ESTER)CARBONATE AND METHOD FOR PRODUCING POLY(ESTER)CARBONATE TEIJIN LIMITED (JP) 2021-12-02 US disclosed
CN-101855189-A Process for producing alcohol MITSUBISHI CHEM CORP 2010-10-06 CN disclosed
US-7491851-B2 Method for generating secondary phosphines BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2009-02-17 US disclosed
US-7256314-B2 Method for generating secondary phosphines BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2007-08-14 US disclosed
US-20070149820-A1 METHOD FOR GENERATING SECONDARY PHOSPHINES BUSACCA CARL A 2007-06-28 US disclosed
US-20050203314-A1 Method for generating secondary phosphines BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2005-09-15 US disclosed
WO-2005068479-A1 A METHOD FOR GENERATING SECONDARY PHOSPHINES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2005-07-28 WO disclosed
US-6492532-B2 Method for producing carbonyl compound by dehydrogenating alcohol MITSUBISHI CHEMICAL CORPORATION (JP) 2002-12-10 US disclosed
US-20020002289-A1 Method for producing carbonyl compound by dehydrogenating alcohol MITSUBISHI CHEMICAL CORPORATION (JP) 2002-01-03 US disclosed
EP-1160245-A1 PROCESS FOR PRODUCING CARBONYL COMPOUNDS BY DEHYDROGENATION OF ALCOHOLS MITSUBISHI CHEMICAL CORPORATION (JP) 2001-12-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070149820-A1 METHOD FOR GENERATING SECONDARY PHOSPHINES HRH3, DBH, HDHD5 TDP1 3013/4885TAAR1 543/4885LMNA 4764/4885
US-20050203314-A1 Method for generating secondary phosphines HRH3, DBH, HDHD5 TDP1 3013/4885TAAR1 543/4885LMNA 4764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.